STRS Ohio’s Aardvark Therapeutics AARD Stock Holding History

STRS Ohio’s Portfolio AARD Stock Details AARD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,100	Closed	-$14.6K	–	2284
2025 Q3	$14.6K	Hold	1,100	–	–	﹤0.01%	2135
2025 Q2	$14.9K	Buy	+1,100	New	+$11.3K	﹤0.01%	2147

Other funds holding AARD

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's AARD Position: Q4 2025 in Review

STRS Ohio sold out of Aardvark Therapeutics (AARD) in Q4 2025, closing a stake of 1,100 shares — an estimated $14.6K sold.

STRS Ohio first reported a position in AARD in Q2 2025 and held it in 2 quarters. The position peaked at $14.9K in Q2 2025. 66 funds tracked by Wall St. Rank hold AARD as of Q4 2025.

STRS Ohio reported no remaining Aardvark Therapeutics position as of Q4 2025 after selling out during the quarter.
STRS Ohio sold 1,100 Aardvark Therapeutics shares in Q4 2025, an estimated $14.6K.
STRS Ohio first reported a position in Aardvark Therapeutics in Q2 2025 and held it in 2 quarters.
STRS Ohio's Aardvark Therapeutics position peaked at $14.9K in Q2 2025.
66 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q4 2025.

Based on STRS Ohio's 13F filing for Q4 2025, filed 2 Feb 2026.